Assessing the Risk of Bias in Randomized Trials

Matthew J. Page, Douglas G. Altman, Matthias Egger

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

Abstract

Studies at high risk of bias may distort the results of systematic reviews and meta-analyses. Based on empirical evidence and theoretical considerations, the following sources of bias should be assessed when including randomized trials in a review: bias arising from the randomization process, bias due to deviations from the intended interventions, bias due to missing outcome data, bias in measurement of the outcome, and bias due to selective reporting. The use of summary scores from quality scales is problematic. Results depend on the choice of scale, and the interpretation of the results is difficult. Therefore, judging risk of bias within separate specified bias domains and recording the information on which each judgment is based - the domain-based approach - are preferred. Assessments of risk of bias of included studies should routinely be incorporated in systematic reviews and meta-analyses. Currently, this is best done using sensitivity analyses.

Original languageEnglish
Title of host publicationSystematic Reviews in Health Research
Subtitle of host publicationMeta-Analysis in Context
EditorsMatthias Egger, Julian P.T. Higgins, George Davey Smith
Place of PublicationOxford UK
PublisherJohn Wiley & Sons
Chapter4
Pages55-73
Number of pages19
Edition3rd
ISBN (Electronic)9781119099369
ISBN (Print)9781405160506
DOIs
Publication statusPublished - 2022

Cite this